Plain-English translation of NCT05017766 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers at University Hospital Basel are trying to understand how certain dangerous bacteria survive and resist antibiotics in the human body. By studying samples from patients with infections like urinary tract infections, pneumonia, and deep-seated infections caused by resistant bacteria, scientists hope to discover new strategies to fight these "superbugs" that no longer respond to standard antibiotics.
Antibiotic-resistant bacteria are becoming a serious global health problem—some infections no longer respond to our current medicines. This research aims to understand exactly how these bacteria behave inside infected patients so scientists can develop entirely new approaches to treating them.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would provide routine clinical samples (such as urine or blood) that are normally collected as part of your medical care. Researchers would then analyze these samples using advanced laboratory techniques to study how the resistant bacteria behave and survive. The study also involves collecting basic information about your infection, medical history, and treatment—most of which can come from your existing medical records. There are no experimental medications or procedures involved.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Switzerland